ABSTRACT. It is not known if milk antibody protects infants from herpes simplex virus (HSV) infection. As a first step to test this hypothesis, anti-HSV antibodies were studied in human milk. Paired serum and milk samples were analyzed for anti-HSV antibodies by ELISA, Western blot analysis (WBA), neutralization (NT) plaque assay, and antibody-dependent cellular cytotoxicity (ADCC) assay. Nineteen of the 20 serum samples showed anti-HSV activity by ELISA and ADCC, and 18 showed activity by WBA and NT. We found a significant association between the immunoassays for detection of anti-HSV antibodies in sera. Fewer of the human milk samples showed anti-HSV activity; only one milk sample was positive by ELISA and one by N T assay, four by ADCC and 12 by WBA. The milk sample from the seronegative donor was also negative. We found a poor association of antibody titers in human milk and serum antibody titers using ELISA, NT, and ADCC assays. There was a significant (p = 0.022) association between serum and milk results using WBA. Among the four assays, WBA was the most sensitive for antibody detection. It will be used in an on-going prospective study to determine the role of anti-HSV antibody in the protection against HSV infections in infants. (Pediatr Res 31: 591-595,1992)
mice, rabbits, or humans protected against viral challenge using HSV-1 or HSV-2 (5-10). Acquired protective humoral immunity in neonatal mice has been reported to be derived from the maternal milk ( 1 1, 12) . In mice, unlike humans, milk antibody is absorbed through the gastrointestinal tract.
Human milk has been shown to contain nonspecific and specific antiviral properties ( 13-1 8) . Milk lipids, metabolized into fatty acids and monoglycerides in the infant's stomach by gastric and lingual lipases, have been demonstrated to disrupt HSV and other enveloped viruses, such as measles virus and vesicular stomatitis virus (19, 20) . A nonspecific factor in the aqueous phase of milk has also been reported as having antiviral activity by interfering with virus entry (2 1). This heat-stable nonIg macromolecule was shown to have weak neutralizing activity against HSV-2 (22). Leukocytes in milk comprised primarily of macrophages and neutrophils have been known to phagocytize foreign matter iii vitro (15, 2.3) . They are capable of producing interferon-ac after viral stimulation (24) and killing viral infected cells by an ADCC mechanism (25) .
Secretory IgA, a specific humoral factor in milk, is thought to prevent replication of pathogens in vivo (18) . Studies in humans have linked protection against cholera (26) , Escherichia coli toxin-mediated enteritis (27) , Campylobacter diarrhea (28) , and neonatal rotavirus infection (29. 30) with secretory IgA in milk. A study of the inhibitory effect of human colostrum and milk on oral poliovirus vaccination indicated that secretory IgA from colostrum prevented seroconversion of breast-fed infants (3 1).
There is little data regarding the various types of anti-HSV antibodies in human milk. Although the role of human milk in protection against HSV infection in infants is unknown, we hypothesize that human milk antibody may offer some protection against HSV infection. The first step in approaching this hypothesis was to characterize the presence and type of anti-HSV antibody in human milk. The purpose of this study thus was to compare HSV-specific antibody levels in matched maternal sera and milk samples by ELISA, NT assay, WBA, and ADCC assay.
MATERIALS AND METHODS
Serum and milk sainples. The clinical samples were obtained from women in Mexico City d u~i n g a longitudinal prospective study of the role of human milk regarding protection of infants against acquisition of infectious diseases. Matched maternal serum and milk samples were collected from women ranging from 49 to 158 d postpartum. The milk samples were collected with a breast pump (Egnell, Cary, IL) (28) . The samples were stored and transported frozen at -20°C. In our laboratory, serum samples were heat inactivated at 56°C for 30 min and stored in small aliquots at -20°C until use. Milk samples were separated into aqueous and lipid fractions by centrifugation at 300 x g for 20 min and were stored at -20°C. Aqueous portions were used in all immunoassays. Known HSV-positive and HSV-negative sera were included as controls in all immunoassays. All samples were obtained after informed consent with approval from the Institutional Review Boards of the University of Texas Medical School, Houston, and the Institute of Nutrition, Mexico City.
Antigen preparation. The antigen used for ELISA and WBA consisted of a detergent-solubilized infected-cell lysate. It was prepared by infecting Vero cells with HSV-1 (HE strain) at a multiplicity of infection of 10. After 30 h of incubation, 100% cytopathic effect was observed in the viral flasks. The cells were scraped, pelleted, and washed with PBS containing 0.9 mM CaC12 and 0.5 mM MgC12. The cells were disrupted in TNEN buffer (0.02 M Tris-HCI, pH 8.0.0.1 M sodium chloride, 1 mM EDTA, 0.5% nonidet P-40, and 0.5% sodium deoxycholate) to which protease inhibitors had been added (0.24 trysin inhibitory units/ mL aprotinin and 1 mM phenylmethylsulfonyl fluoride, Sigma Chemical Co., St. Louis, MO). CaCl? was added to a concentration of 5 mM, and the mixture was rocked for 30 min at 4°C. The solution was clarified by centrifugation and stored at -70°C in small aliquots. Mock-infected Vero cell lysate, identically prepared, was used as the control antigen. The protein concentrations were determined using the Bio-Rad protein assay (BioRad Laboratories, Richmond, CA), and the viral and mockinfected samples were diluted to 1.8 mg/mL in TNEN, aliquoted, and stored at -70°C.
ELISA. Maternal serum and milk samples were measured in a direct ELISA to determine the level of HSV-specific antibodies. Infected or mock cell lysate diluted to 20 pg/mL in PBS (in 96-well plates; Becton Dickinson, Oxnard, CA) was used as a source of antigen. Serum and milk sample dilutions were incubated with peroxidase-conjugated goat anti-human IgG (for sera) or goat anti-human secretory IgA (for milk) (Sigma Chemical Co.). Dilution and wash buffer consisted of PBS containing 1% goat serum and 0.3% Tween 20 for sera or TNM buffer (50 mM Tris-HCI, pH 7.5, with 200 mM NaCl and 2% nonfat dry milk) (Lucerne, Oakland, CA) for milk samples. Wells were subsequently developed by the addition of substrate buffer containing o-phenylenediamine dihydrochloride. The reciprocal of the sera or milk dilution corresponding to 50% of the peak of the positive control sample signal was considered as the titer. A control experiment using a negative milk sample mixed with a positive serum (1: 1) sample was performed identically to ensure that the conjugate was capable of detecting anti-HSV IgA antibody in milk.
Electrophoresis and WBA. Pre-made 7.5 % SDS-PAGE gels (Bio-Rad Laboratories) were used for electrophoresis. The viral and mock antigen samples were prepared as described above and boiled for 3 min in laemmli sample buffer. Fifty pg protein was loaded in each lane. High molecular weight markers were run as standard controls (Bethesda Research Laboratories, Gaithersburg, MD). The samples were electrophoresed at 90 V for 90 min. Antigens were transferred to nitrocellulose paper using a Hoefer mini-transphor unit (Hoefer Scientific Instruments, San Francisco, CA). Transfer was carried out for 45 min at 75 V. After soaking in TNM for 30 min, the nitrocellulose paper was cut into strips corresponding to the well lanes and incubated at 4°C overnight with 1/100 dilution of sera in TNM, or 1/4 dilution of human milk in TNM containing 10% background reduction buffer (Calypte Biomedical, Berkeley, CA). The following day, the strips were subjected to three 10-min washes in TNM and incubated in a 1/500 dilution of peroxidase-conjugated goat anti-human IgG (serum blots) or at a 1/200 dilution of goat anti-human secretory IgA (milk blots) (Sigma Chemical Co.) for 1 h at room temperature. Excess conjugate was removed with three consecutive washes with PBS containing 0.1 % Triton X-100. The strips were developed for 10 min using 1.0 mg/mL chloro-I-naphthol dissolved in cold methanol, 10 mM Tris-HC1, pH 7.5, 50 mM NaC1, and 0.016% hydrogen peroxide. The resulting Western blots were dried and photographed. The blots were rated +, ++, or +++ according to the intensity of the bands, with + representing weak, ++ as medium intensity, and +++ as dark bands. To identify specific viral protein bands on the human serum and milk sample blots, murine MAb, which recognized various glycoproteins including gB, gD, and gE [provided by Drs. Lenore Pereira (University of California, San Francisco) and Harvery Friedman (University of Pennsylvania)] were reacted with the viral antigen blots. MAb binding was detected with peroxidase-conjugated goat anti-mouse IgG followed by development. In addition, a control experiment that used a positive serum sample mixed with a negative milk sample at a 1/10 dilution as the primary antibody mixture was done to confirm that it was possible to detect HSV-specific IgA by Western blot in the presence of milk.
NT assay. NT assays were performed by incubating serial dilutions of serum or milk with approximately 50 plaque forming units of HSV-1 (HE strain) for 1 h at 37°C. This mixture was adsorbed on Vero cell monolayers in duplicate using six-well plates, for 1 h at 37°C. The inoculum was removed and the cells were overlayed with media containing 0.5% agarose. After a 3-d incubation at 37"C, the agarose overlay was removed, and monolayers were stained. The reciprocal of the dilution of serum or milk that resulted in a 50% or greater reduction of plaques was reported as the NT titer.
ADCC assuy. Microcytotoxicity assays were performed as previously described (3, 5) . Chang liver cells infected with HSV-1 and labeled with radioactive sodium chromate were used in an 18-h ADCC assay. Effector cells were mononuclear leukocytes isolated from heparinized human peripheral blood used at an effector to target ratio of 50:l. Serial dilutions of the serum or milk samples starting at 1/20 were added to the appropriate wells, resulting in a final volume of 200 pL. A control experiment using a negative milk sample mixed with an equal volume of a seropositive serum sample was also performed to ensure efficient detection of serum ADCC activity in the presence of milk. 
RESULTS
A summary of ELISA titers, WBA results, NT titers, and ADCC titers is given in Table 1 . Anti-IgA conjugate was used for milk ELISA and WBA, whereas anti-IgG conjugate was used for sera ELISA and WBA. The samples are arranged in order of descending ELISA titers. One woman (no. 20) did not show activity against HSV in her serum or milk in any of the assays and was classified as seronegative regarding HSV. Subject 19 was weakly seropositive. Low ELISA and ADCC titers were obtained (30 and 320, respectively), but her serum was nonneutralizing and gave no reaction by WBA. The sera of the remaining 18 women had positive anti-HSV activity with ELISA titers ranging from 530 to 3460, NT titers between 80 and 1 280, ADCC titers from 1 280 to 20 480, and multiple strong bands on Western blots. When comparing results of assays of serum samples, there was a 100% concordance between WBA and NT and 95% concordance among all four assays. When log values were compared, correlations ranged from 0.76 to 0.90, indicating that all possible pair correlations were significantly correlated. The correlations became poor when serum specimens from the two mothers that gave negative or low values were excluded. In summary, all assays agree in dichotomizing absent versus present serum antibody but have a poor correlation regarding quantity of antibody. Milk from the 18 seropositive women demonstrated relatively few positive results. Only one sample (subject 1) showed significant anti-HSV activity by ELISA with a titer of 15. It also had the highest ADCC titer, 320, and was positive by WBA. All other milk samples were negative by ELISA. Similarly, only one milk sample (subject 18) had activity in the NT assay, with a titer of 80. It was also positive by WBA (+), but was ELISA and ADCC negative. Most of the milk samples did not mediate ADCC, with only four samples being positive. As noted, subject 1 had an ADCC titer of 320, and subjects 7, 9, and 14 had titers of 20.
Although there were relatively few positive milk results in the ELISA, NT, and ADCC assays, 12 of the 20 milk samples showed reactions with a variety of virus-specific proteins by WBA. The eight negative Western blots included sample 20, which came from an HSV seronegative donor, sample 19 from a weak HSV seropositive donor, and samples 3, 4, 8, 9, 12, and 13 from seropositive donors. This indicated a poor agreement between results from the NT, ADCC, and ELISA in the milk system. Nevertheless, there was a significant ( p = 0.022) correlation between serum IgG and milk IgA anti-HSV antibody detected by WBA. Mothers with serum antibody titers of 3+ were significantly (p = 0.002) more likely to have positive milk samples.
The pattern of bands on the IgG serum blots was not reflective of the IgA milk blots on a sample per sample basis. In general, the serum blots showed many more viral specific bands than the milk blots. There was no reaction of the sera with proteins found in the mock antigen, but several of the milk samples reacted slightly with mock antigen. At least one to two dozen HSVspecific bands appeared with all positive serum samples. The multitude of bands on the serum blots made it difficult to determine the identity of individual bands. In some cases, bands were too close to be clearly resolved. Murine MAb to glycoprotein B, D, and E were used as a source of specific antibody in an attempt to identify some of the viral bands. Three of the serum samples (nos. 2, 7, and 18) appeared to react with a band that migrated between 220 and 230 kD, and three sera (samples 6, 10, and 18) reacted to a protein of about 130 kD, which probably corresponds to glycoprotein C. Many of the serum samples reacted with bands between 100 and 120 kD (samples 1-6, 8-13, 15, 17, and 18) ; glycoprotein B migrates in this region. The sera also reacted with a large number of bands ranging from 25 to 83 kD, where glycoproteins D (59 kD) and E (70 kD) are found. The 12 positive milk samples seemed to fall into three main groups: those that reacted with at least a dozen viral proteins over a large range of molecular weights (samples 2, 5-7, 1 1, and 1 3 , those that reacted rather strongly with only one or two proteins (samples 1 and 16), and those that reacted predominantly to proteins with the lower molecular weights, between 30 and 45 kD (samples 10 and 14) .
Because we were unable to detect anti-HSV activity in many of the milk samples, antibody addition experiments were performed to check the ability of the ELISA, WBA, and ADCC assay to detect anti-HSV antibody in milk. In each case, serum from an HSV antibody-positive donor was mixed with a milk sample that was obtained from a seronegative donor (see Materials and Methods for details of mixing experiments). In the ELISA assay, the mixed sample using this anti-IgA conjugate resulted in a titer of 29 and the positive serum had an anti-IgA HSV titer of 18 when tested alone. By WBA using an anti-IgA conjugate, identical patterns of bands were observed with the mixed sample and positive serum. Identical titers of 1280 were obtained in the ADCC assay when the mixed sample was compared with the positive serum alone. These experiments confirmed that the ELISA, WBA, and ADCC would have detected anti-HSV IgA antibody in milk had there been a sufficient amount present and that our negative milk results were not due to a nonspecific inhibitory effect of milk.
DISCUSSION
There is a dearth of information regarding functional anti-HSV antibody in human milk. This is the first study to use four immunoassays, ELISA, WBA, NT, and ADCC to compare HSVspecific antibody activity in maternal sera to activity in milk. Our results indicated a close agreement among the immunoassays for the measurement of HSV-specific antibody in human sera. Similar results for the detection of HSV antibody in serum specimens by these four assays have been reported (32) (33) (34) (35) . However, our results demonstrated less agreement between the immunoassays in the milk system. Few milk samples had detectable anti-HSV activity, and the samples with activity had titers that were considerably lower than the serum samples.
Similar discrepancies have been reported by Lopez et al. (22) for detection of anti-HSV antibodies in milk by ELISA and NT assay.
Human milk is a complex mixture of protein, carbohydrates, and lipids and has been shown to have inhibitory effects in several immunoassays. To prove that the immunoassays were capable of detecting HSV-specific IgA antibody in the milk, experiments using negative milk mixed with serum from HSVpositive donors were performed. The positive results confirmed that the ELISA. WBA, and ADCC assays were capabl~ of detecting anti-HSV antibody in human milk and that the aqueous fraction of milk does not appear to contain inhibitory factors that interfere with antibody detection in these assays. Although colostrum has been shown to inhibit ADCC effector cell function (25) , the negative ADCC milk titers were not due to this effect. Low or absent milk ADCC titers were not surprising because ADCC to HSV-infected cells has been shown to be mediated by IgG and not IgA, which is the predominant milk antibody (36) . The negative NT and ELISA results could be explained by the milk samples being obtained 49 to 158 d postpartum and thus having antibody levels that were too low to be detected by these assays. It has been previously shown that milk antibody levels diminish with time from birth (37) . Furthermore, the immediate freezing of samples should have prevented the generation of nonantibody-mediating neutralizing substances, such as fatty acids, and thereby decreased nonspecific neutralization (19) .
Most of the milk Western blots showed a positive signal, although many of the milk samples were negative by ELISA, NT, and ADCC assays. One explanation for this discrepancy is the different levels of sensitivity of the immunoassays, especially for detection of IgA. The large amount of viral antigen, the high concentration of milk, and the overnight incubation step could have made the WBA more sensitive than the ADCC, ELISA, and NT assays. Although WBA is not a functional assay, its increased sensitivity suggests its utility to detect milk antibody to HSV antigens.
The clinical significance of these results has yet to be determined. Breast-feeding has been associated with protection against gastrointestinal tract infections (enteromammary axis of immunity) (38) , such as those caused by E. coli, Vibrio cholerae, Campylobacter, and Shigella (26, 28, (39) (40) (41) . Protection against respiratory tract infections (bronchomammary axis) is less definite. However, studies do exist that show that breast-feeding protects against upper respiratory tract infections, including those associated with Haeinophilus influenzae (42) (43) (44) (45) , otitis media (46) , and lower respiratory tract infections (47) . Although protection has been demonstrated, most of these studies do not link this protection to a specific component in milk. High anti-HSV ADCC antibody titers in maternal and neonatal sera have been linked to protection against the disseminated form of neonatal HSV (3). Studies evaluating colostral leukocytes have shown them to mediate ADCC in vitro (24) , but inasmuch as ADCC antibody was not present in this study, their role in vivo in this situation is questionable. Five studies have identified secretory IgA in human milk as the protective agent in the prevention of illness (26) (27) (28) (29) (30) . However, the possible role of anti-HSV IgA milk antibodies as detailed by WBA in protection against HSV infection is currently unknown. An ongoing prospective study by our group of HSV infection in breast-fed infants should provide further information regarding the role of breast-feeding and the specific role of HSV antibody in prevention or amelioration of this disease.
